Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-020697
Filing Date
2025-02-14
Accepted
2025-02-14 11:54:05
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 17507
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 54577
3 EX-99.2 ck0001669811-ex99_2.pdf EX-99.2 57115
4 EX-99.3 ck0001669811-ex99_3.pdf EX-99.3 116001
  Complete submission text file 0000950170-25-020697.txt   333749
Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-8001
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

EIN.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 900 MIDDLESEX TURNPIKE BILLERICA MA 01821
Business Address 900 MIDDLESEX TURNPIKE BILLERICA MA 01821 617-301-9400
Quanterix Corp (Subject) CIK: 0001503274 (see all company filings)

EIN.: 208957988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90285 | Film No.: 25625297
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)